NICE To Reassess English Funding Rejections Of Leqembi And Kisunla After Successful Appeals

Alzheimer's Disease And Picture Of Brain On Blocks
Leqembi and Kisunla target early-stage Alzheimer’s disease (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Health Technology Assessment

More from Market Access